The assessment of PD-L1 staining in immunohistochemistry was done based on four different scores: i) PD-L1 expression in tumor cells in terms of tumor proportion score, ii) PD-L1 expression in tumor associated immune cells, iii) combined positive score and iv) PD-L1 expression in interface pattern. The gene discussed is CD274; the disease is neoplasm.